859940-73-1

Basic information

• Product Name: 1-BroMo-3-(Methylsulfonyl)propane
• Synonyms: 1-BroMo-3-(Methylsulfonyl)propane;1-broMo-3-Methanesulfonylpropane
• CAS NO: 859940-73-1
• Molecular Formula: C4H9BrO2S
• Molecular Weight: 201.08206
• Mol File: 859940-73-1.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-BroMo-3-(Methylsulfonyl)propane(CAS DataBase Reference)
• NIST Chemistry Reference: 1-BroMo-3-(Methylsulfonyl)propane(859940-73-1)
• EPA Substance Registry System: 1-BroMo-3-(Methylsulfonyl)propane(859940-73-1)

Safety Data

• Hazardous Substances Data: 859940-73-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1-Bromo-3-(methylsulfonyl)propane is used as a reagent and intermediate for the synthesis of various pharmaceuticals, contributing to the development of new drugs and improving existing ones.
Used in Agrochemical Industry:
In the agrochemical industry, 1-Bromo-3-(methylsulfonyl)propane serves as a reagent and intermediate in the production of agrochemicals, aiding in the creation of more effective and safer products for agricultural use.
Used in Organic Synthesis:
1-Bromo-3-(methylsulfonyl)propane is utilized as a solvent in organic synthesis, facilitating various chemical reactions and contributing to the advancement of organic chemistry.

Upstream product

• 109-64-8 1,3-dibromo-propane 
• 5188-07-8 sodium thiomethoxide 
• 2058-49-3 3-(methylsulfonyl)propan-1-ol 
• 109-70-6 1.3-chlorobromopropane 

Downstream Products

• 1613619-34-3 5-[4-cyano-2-(3-dimethylamino-prop-1-ynyl)-phenyl]-2-(3-methanesulfonyl-propyl)-7-methyl-3-oxo-8-(3-trifluoromethyl-phenyl)-2,3,5.,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrimidine-6-carboxylic acid methyl ester 
• 1613619-48-9 (3-{5-cyano-2-[(R)-6-methoxycarbonyl-7-methyl-3-oxo-8-(3-trifluoromethyl-phenyl)-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrimidin-5-yl]-phenyl}-propyl)-(3-methanesulfonyl-propyl)-dimethyl-ammonium formate 
• 1571033-05-0 1-(3-(3-(methylsulfonyl)propoxy)benzyl)-6-oxo-1,6-dihydropyridine-3-carbonitrile 

Relevant articles and documents

PYRIMIDINE OR PYRIDOPYRIDONE COMPOUND AND APPLICATION THEREOF

The present invention discloses a pyrimidine or pyridopyridone compound as shown in formula (I) and an application thereof relating to the technical field of medicament preparation. The compound can selectively suppress cyclin-dependent kinases (Cdks) CDK

Imidazole derivative used as antiviral agent and use thereof in preparation of medicament

Disclosed are an antiviral compound and a use thereof in the preparation of a medicament for the treatment of virus infections. Specifically, the present invention relates an imidazole derivative for treating respiratory syncytial virus infection.

NOVEL 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH HETEROCYCLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

The present invention is concerned with novel 1,3-dihydro-2H-benzimidazol-2-one derivatives substituted with heterocycles having formula (I) stereoisomeric forms thereof, and the pharmaceutically acceptable addition salts, and the solvates thereof, wherei

SPIRO UREA COMPOUNDS AS RSV ANTIVIRAL COMPOUNDS

The invention concerns novel substituted spiro urea azetidinyl or piperidinyl compounds of formula (I) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention furth

RSV ANTIVIRAL COMPOUNDS

Inhibitors of RSV replication of formula RI including stereochemically isomeric forms, and salts or solvates thereof, wherein R22, W, Q, V, Z p,s,and Het have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other RSV inhibitors, in RSV therapy.

QUINOXALINONES AND DIHYDROQUINOXALINONES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

Quinoxalinones and dihydroquinoxalinones having inhibitory activity on RSV replication and having the formula (I) including addition salts, and stereochemically isomeric forms thereof; compositions containing these compounds as active ingredient and processes for preparing these compounds and compositions.

NOVEL COMPOUNDS

Compounds of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for treating diseases and conditions in which HNE is implicated.

NOVEL COMPOUNDS

This invention relates to heterocyclic compounds, which are pyrimidinone derivatives having human neutrophil elastase inhibitory properties, and their use in therapy.

HETEROCYCLIC INHIBITORS OF GLUTAMINASE

The invention relates to the heterocyclic compounds of Formula (I) as defined further herein, and pharmaceutical preparations thereof. The invention further relates to methods of treating cancer, immunological or neurological diseases using the heterocyclic compounds of the invention.

INDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

Indoles having inhibitory activity on RSV replication and having the formula I the prodrugs, N-oxides, addition salts, quaternary amines, metal complexes and stereochemically isomeric forms thereof; compositions containing these compounds as active ingredient and processes for preparing these compounds and compositions.